Avinger (NASDAQ:AVGR) Now Covered by StockNews.com

Posted by on Mar 27th, 2025

Research analysts at StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the medical device company’s stock.

Avinger Stock Performance

AVGR opened at $0.47 on Wednesday. Avinger has a twelve month low of $0.36 and a twelve month high of $4.37. The business’s 50 day moving average is $0.50 and its 200-day moving average is $0.74. The stock has a market cap of $1.57 million, a PE ratio of -0.04 and a beta of 1.09.

Avinger Company Profile

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

Further Reading

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.